Because the inhibition of NEK4 sensitize cells to TRAIL-mediated cell death in vitro, we further examined whether the depletion of NEK4 enhance the anti-tumor activity of TRAIL in vivo. The gene discussed is TNFSF10; the disease is neoplasm.